World Health Organization
20 JULY 2011 | GENEVA – The use of currently available commercial blood (serological) lests to diagnose active tuberculosis (TB) otten leads to misdiagnosis, mislrealment and potential harm to public health, says WHO in a policy recommendation issued today. WHO is urging countries to ban the inaccurate and unapproved blood tests and instead rely on accurate microbiological or molecular tests, as recommended by WHO
Read more
WHO report